Atlas Trials

Different Doses of Oral Melatonin Supplements in Chronic Kidney Disease (CKD)-Associated Sleep Disorders

Clinical trial NCT01922999 · UNKNOWN

Trial details

NCT number
NCT01922999
Sponsor
Southeast Renal Research Institute
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
End Stage Renal DiseaseChronic Kidney DiseaseSleep Disorder
Start date
2012-12-01
Primary completion
2017-12-01
Enrollment
53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.